Groupe Athena Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,440.70
6,501.60
4,613.30
6,451.40
1,356.40
6,394.10
Depreciation, Depletion & Amortization
2,491.10
2,581.60
2,708.50
1,446.50
202.00
406.50
Funds from Operations
7,931.80
9,083.30
7,321.80
7,897.90
1,558.30
6,800.60
Changes in Working Capital
270.20
483.60
15.30
19.30
20.00
76.30
Net Operating Cash Flow
7,661.50
8,599.60
7,337.00
7,878.60
1,538.30
6,724.20
Capital Expenditures
1,442.50
4,357.00
3,122.30
6,046.10
142.20
Purchase/Sale of Investments
4,235.40
4,156.30
4,198.30
1,175.10
1,141.40
Net Investing Cash Flow
7,628.30
8,513.30
7,320.70
7,829.70
1,530.20
Net Change in Cash
33.20
86.30
16.40
48.80
8.10
Free Cash Flow
6,219.00
8,511.80
6,426.10
7,448.40
1,538.30
Other Uses
1,950.40
-
-
608.50
246.70

About Groupe Athena

View Profile
Address
10/234 Dadisheth Agiary Lane
Mumbai Maharashtra 400002
India
Employees -
Website http://www.groupeathena.com
Updated 07/08/2019
Groupe Athena, Inc. engages in the provision of pharmaceutical research and testing services. It is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the U. S.